Company Overview and News
Calumet Specialty Products Partners (CLMT), an MLP involved in the production of specialty fuels and other refined products, was the top MLP gainer in the week ending June 1. Calumet Specialty Products Partners rallied 23.9%. Last week, the gains could have been due to strong refined products demand during Memorial Day weekend and the start of the summer driving season. Calumet Specialty Products Partners has traded in the green for 2018 following last week’s rally.
NGL LGCYP LGCYO CLMT NGL.PRB ENLK ENLC CEQP NS.PRC NS.PRB NSH LGCY CVRR ENBL NS NS.PRA
It's a perennial favorite, with investors and industry insiders requesting it over and over again. We wanted to provide a simple number that could be referenced and compared. Something like the GDP growth rate, which on its face is a quick look at the economy, but in reality, is a simplified summary of a nuanced subject.
LINEQ ETP.PRC LGCYP LGCYO BBPPQ LNGG VNRR BBEP WPZ ETP VNR LGCY VNRAP VNRBP VNRCP BBEPQ EEP PAA BBEPP LINE
Legacy Reserves (LGCY), the upstream MLP involved in crude oil, natural gas, and NGLs (natural gas liquids) production, was the top MLP loss last week. Legacy Reserves fell 36.2% mainly due to the weakness in crude oil prices. Although Legacy Reserves has fallen significantly from its YTD highs, it’s still up 217.4% in 2018. The stock might continue to see high volatility in the near term due to strong movements in crude oil prices.
CCLP LGCYP SDLP LGCYO AMID LGCY SDRL SXE PAA BPL HCLP SNMP
Legacy Reserves (LGCY), an upstream MLP involved in crude oil, natural gas, and NGLs (natural gas liquids) production, was upgraded by UBS in the week ending May 18. UBS upgraded Legacy Reserves to “neutral,” which is equivalent to a “hold” from “sell.” UBS increased Legacy Reserves’ target price to $8 from $1.5. Currently, only one analyst has coverage on Legacy Reserves. The partnership is trading above its target price.
LGCYP TCP LGCYO GMLP HMLP GLOP.PRA GLOP.PRB LGCY GLOP HMLP.PRA TEP
The 10-year U.S. Treasury has crossed the rubicon. It is now flashing a yield that is over the 3% mark. What befalls the economy when that happens? Recession? Correction? A grinding bear market?
SVA BCML SSBI LGCY SYNL PFIE NTIC
In this part, we’ll discuss the top percentage gainers from the upstream sector in the US for the week starting on May 14. To compile the list of the top upstream gainers, we only used oil and gas producers with market capitalizations greater than $100 million and an average trading volume greater than 100,000 shares last week.
CKRGZ LGCYP LGCYO CHKVP CRK CHKDH CHKVZ CHKDG CHKWZ CHKDJ EGC CHKDP CHK.WI CHK LGCY CHK.PRD
The three only mark an acceleration of the trend of MLP "roll-ups," however. Many others have been announced in 2018.
ARLP LGCYP APLP LGCYO CQP EBGUF RMP AROC ENB TEP TEGP SEP NSH EQM WPZ WMB EQGP EEP LNG BWP L ENB ENF LGCY
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION
13h - Asif
History and Development Himax Taiwan, its predecessor, was incorporated on June 12, 2001 as a limited liability company under the laws of the ROC. On April 26, 2005, the company established Himax Technologies Limited, an exempted company with limited liability under the Cayman Islands Companies Law, as a holding company to hold the shares of Himax Taiwan in connection with its reorganization and share exchange. On October 14, 2005, Himax Taiwan became its wholly owned subsidiary through a share exchange consummated pursuant to the ROC Business Mergers and Acquisitions Law through which the company acquired all of the issued and outstanding shares of Himax Taiwan, and the company issued ordinary shares to the shareholders of Himax Taiwan. Shareholders of Himax Taiwan received one of its ordinary shares in exchange for one Himax Taiwan common share. The share exchange was unanimously approved by shareholders of Himax Taiwan on June 10, 2005 with no dissenting shareholders and by ...
2018-06-22 - Asif
Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...
2018-06-22 - Asif
Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...
Silicon Investor Message Boards
This table lists all message boards related to LGCY / Legacy Reserves LP on message board site Silicon Investor.
|SPIDER u0026 RICOu0027S u0027NO-BASHu0027 THREAD FOR LGCY !!!|
as of ET